In hereditary spastic paraplegia type 50 (SPG50)—an ultrarare form of neurodevelopmental/neurological disorder described as ideal for gene therapy—Canadian researchers successfully created and completed a...
Since their discovery in the 1950s, adenoviruses have been increasingly recognized as versatile and powerful gene therapy and vaccine development tools. By 1994, the...
